Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union.
Patel H, Ton TGN, Davies J, Fear S, Block C, Tanaka K, Gonzalez D, Mutter R, Alfaro-Oliver N, Mendez I, Qizilbash N.
Patel H, et al. Among authors: mendez i.
Pharmaceut Med. 2021 Nov;35(6):339-351. doi: 10.1007/s40290-021-00407-7. Epub 2021 Dec 7.
Pharmaceut Med. 2021.
PMID: 34877624
Free PMC article.